Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
Preferred Name | Therapeutic Hemin | |
Synonyms |
|
|
Definitions |
A sterile, lyophilized powder of hemin, the Fe3+ oxidation product of heme (Fe2+), derived from processed red blood cells. Therapeutic hemin appears to inhibit delta-aminolevulinic acid (ALA) synthetase, a rate-limiting enzyme in the porphyrin/heme biosynthetic pathway, resulting in inhibition of the hepatic and/or marrow synthesis of porphyrin precursors. The mechanism by which therapeutic hematin produces symptomatic improvement in patients with acute episodes of the hepatic porphyrias has not been determined. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C68925 |
|
code |
C68925
|
|
definition |
A sterile, lyophilized powder of hemin, the Fe3+ oxidation product of heme (Fe2+), derived from processed red blood cells. Therapeutic hemin appears to inhibit delta-aminolevulinic acid (ALA) synthetase, a rate-limiting enzyme in the porphyrin/heme biosynthetic pathway, resulting in inhibition of the hepatic and/or marrow synthesis of porphyrin precursors. The mechanism by which therapeutic hematin produces symptomatic improvement in patients with acute episodes of the hepatic porphyrias has not been determined.
|
|
in_subset | ||
label |
Therapeutic Hemin
|
|
Legacy Concept Name |
Therapeutic_Hemin
|
|
NCI_Drug_Dictionary_ID |
549706
|
|
PDQ_Closed_Trial_Search_ID |
549706
|
|
PDQ_Open_Trial_Search_ID |
549706
|
|
Preferred_Name |
Therapeutic Hemin
|
|
prefixIRI |
NCIT:C68925
|
|
prefLabel |
Therapeutic Hemin
|
|
Semantic_Type |
Pharmacologic Substance
|
|
UMLS_CUI |
C0030316
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping
Mapping To | Ontology | Source |
---|---|---|
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C68925 | NCIT | LOOM |
http://purl.bioontology.org/ontology/PDQ/CDR0000549706 | PDQ | LOOM |